SCHEMBL29536830

SCHEMBL29536830

CNc1ncc2c(C)c(Br)c(NCCO)nc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 2/20 0.40
▸ CCNA2 P20248 6/20 0.37
▸ CDK2 P24941 6/20 0.37
▸ CCNA1 P78396 6/20 0.37
▸ EGFR P00533 3/20 0.37
▸ POLB P06746 1/20 0.35
▸ KMT2A Q03164 4/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TAAR1 Q96RJ0 1/20 0.33
▸ TYRO3 Q06418 1/20 0.32
▸ MERTK Q12866 1/20 0.32
▸ GAS6 Q14393 1/20 0.32
▸ PGK1 P00558 1/20 0.32
▸ TNF P01375 1/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25230025 1.00 FLT3 (0.40) FLT3CCNA2CDK2CCNA1EGFR
SCHEMBL27103103 0.76 FLT3 (0.39) FLT3CCNA2CDK2CCNA1EGFR
SCHEMBL30595895 0.76 FLT3 (0.39) FLT3CCNA2CDK2CCNA1EGFR
SCHEMBL25225986 0.76 FLT3 (0.39) FLT3CCNA2CDK2CCNA1EGFR
SCHEMBL30595901 0.74 ROCK1 (0.32) —
SCHEMBL25269634 0.74 ROCK1 (0.32) —
SCHEMBL25223077 0.73 CCNA2 (0.40) CCNA2CDK2CCNA1EGFRPOLB
SCHEMBL29537006 0.73 CCNA2 (0.40) CCNA2CDK2CCNA1EGFRPOLB
SCHEMBL25221516 0.66 KDM4E (0.51) FLT3CDK2POLBKMT2AMAPK1
SCHEMBL29313773 0.66 CCNA2 (0.46) FLT3CCNA2CDK2CCNA1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116710453-A Kinase inhibitors and uses thereof 璧辰医药技术股份有限公司 2023-09-05 — — CN disclosed
EP-4192582-A1 KINASE INHIBITORS AND USES THEREOF ABM Therapeutics Corporation (US) 2023-06-14 — — EP disclosed
WO-2022032071-A1 KINASE INHIBITORS AND USES THEREOF ABM THERAPEUTICS CORPORATION (US) 2022-02-10 — — WO disclosed
Send feedback